Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
23%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
30%
ALSO IN AGNG
AGNG
84
HOLDINGS
10%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus AGNG)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 17.1% | 3.3% | 3.3% | |
| ABBVIE INC | 8.2% | 3.1% | 3.1% | |
| BRISTOL-MYERS SQUIBB CO | 4.8% | 3.0% | 3.0% | |
| JOHNSON & JOHNSON | 5.5% | 2.9% | 2.9% | |
| AMGEN INC | 3.9% | 2.9% | 2.9% | |
MEDX Overweight Relative to AGNG
| ELI LILLY & CO | 13.8% | |
| NOVARTIS AG-ADR | 7.2% | |
| ABBVIE INC | 5.1% | |
| IONIS PHARMACEUTICALS, INC. | 4.7% | |
| ALKERMES PLC | 4.4% | |
| ALNYLAM PHARMACEUTICALS INC | 3.6% | |
| PFIZER INC | 3.3% | |
| BIOGEN IDEC INC | 3.1% | |
| GLAXOSMITHKLINE PLC-SPON ADR | 2.8% | |
| JOHNSON & JOHNSON | 2.6% |
MEDX Underweight Relative to AGNG
| NOVO NORDISK A/S-B | -3.9% | |
| WELLTOWER, INC. | -3.2% | |
| EDWARDS LIFESCIENCES CORP | -3.2% | |
| VENTAS INC | -3.2% | |
| ROCHE HOLDING AG-BR | -3.2% | |
| CHUGAI PHARMACEUTICAL CO LTD | -2.8% | |
| STRYKER CORP | -2.8% | |
| UCB SA | -2.7% | |
| MEDTRONIC PLC | -2.7% | |
| BOSTON SCIENTIFIC CORP | -2.7% |